Company profile: RxData
1.1 - Company Overview
Company description
- Provider of a global market access data platform offering on-demand, automated pharmaceutical pricing and reimbursement insights. Solutions include comprehensive market access intelligence, exportable dashboards, real-time monitoring of 100+ sources, curated HTA/regulatory data, visible net price algorithms, and an internal data repository.
Products and services
- RxData Platform: An automated repository housing the largest database of pharmaceutical product prices and reimbursement decisions plus regulatory and HTA publications to streamline market access intelligence for life science commercialization
- Real-Time Data Monitoring: Real-time tracking of over 100 data sources, delivering up-to-date market access, pricing, and reimbursement information to inform decisions across drugs, indications, and manufacturers
- Market Access Dashboards: Exportable dashboards presenting Events, Coverage, and Pricing views, searchable by drugs, indications, or manufacturers to visualize market access events, coverage decisions, and pricing information
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to RxData
Schrödinger
HQ: United States
Website
- Description: Provider of physics-based molecular discovery and design software platforms for therapeutics and materials research, supporting biopharmaceutical and industrial companies, academic institutions, and government labs; offers collaborative and wholly-owned drug discovery programs and pipeline, educational resources and courses, and tools to model and optimize metals, alloys, and ceramics via computational workflows and machine learning.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Schrödinger company profile →
Academia.edu
HQ: United States
Website
- Description: Provider of the largest and fastest-growing platform for sharing academic research, enabling academics to share research papers and aiming to accelerate and democratize academic research. Over 150 million academics have signed up, adding 25 million papers, with more than 100,000 people joining each day.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Academia.edu company profile →
Symyx
HQ: United States
Website
- Description: Provider of scientific enterprise software for chemical, materials, and bioscience research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Symyx company profile →
Cellarity
HQ: United States
Website
- Description: Provider of AI and single-cell omics–driven drug discovery solutions, including the Cellarity Platform to address cellular dysfunction across diseases; the Intervention Library to predict perturbation impacts on cell behaviors; the Cellarity Map to identify gene networks from health to disease; a drug discovery pipeline in hematology and immunology; and a MASH collaboration with Novo Nordisk.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cellarity company profile →
ClinApps
HQ: United States
Website
- Description: Provider of software development and consulting services, creating state-of-the-art systems for the pharmaceutical and biotechnology industries. Established in 1999 with international offices, the company leverages a full-time staff of highly skilled industry professionals to deliver high-quality end-to-end solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ClinApps company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for RxData
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to RxData
2.2 - Growth funds investing in similar companies to RxData
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for RxData
4.2 - Public trading comparable groups for RxData
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →